A Pilot Study of Mitoxantrone in Combination with Clofarabine (MITCL) in Children, Adolescents and Young Adults (CAYA) with Refractory/Relapsed Acute Leukemia

被引:0
|
作者
Hochberg, Jessica C. [1 ]
Oesterheld, Javier [2 ]
Miitano, Olga [1 ]
Harrison, Lauren [1 ]
Cairo, Mitchell S. [1 ,3 ,4 ,5 ,6 ]
机构
[1] New York Med Coll, Pediat, Valhalla, NY 10595 USA
[2] Levine Childrens Hosp, Pediat Blood & Marrow Transplantat, Charlotte, NC USA
[3] New York Med Coll, Pathol, Valhalla, NY 10595 USA
[4] New York Med Coll, Cell Biol & Anat, Valhalla, NY 10595 USA
[5] New York Med Coll, Microbiol & Immunol, Valhalla, NY 10595 USA
[6] New York Med Coll, Med, Valhalla, NY 10595 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页数:3
相关论文
共 50 条
  • [31] Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory acute lymphoblastic leukemia in adults.
    Krawczyk, M
    Giebel, S
    Jakubas, B
    Cioch, M
    Palynyczko, G
    Holowiecki, J
    BLOOD, 2003, 102 (11) : 883A - 883A
  • [32] Treatment of children with relapsed acute myeloid leukemia with gemtuzumab in combination with mitoxantrone and cytarabine.
    Aplenc, R
    Alonzo, TA
    Gerbing, R
    Smith, FO
    Eric, S
    Arceci, RJ
    BLOOD, 2005, 106 (11) : 239B - 239B
  • [33] CLOFARABINE, CYTARABINE AND MITOXANTRONE FOR RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA - INTERIM RESULTS OF A PROSPECTIVE PHASE 2 STUDY
    Gill, H.
    Ip, H. W.
    Yip, S. F.
    Kho, B.
    Lee, H.
    Mak, V.
    Lau, J.
    Lau, C. K.
    Lin, S. Y.
    Wong, R.
    Li, W.
    Kwong, Y. L.
    HAEMATOLOGICA, 2017, 102 : 677 - 677
  • [34] Pilot study of Mylotarg (Gemtuzumab Ozogamicin) and mitoxantrone in relapsed/refractory acute myelogenous leukemia and high risk myelodysplasia.
    Nichols, GL
    Diuguid, D
    Crescenzo, K
    Sharpe, E
    Hesdorffer, C
    Fine, R
    BLOOD, 2003, 102 (11) : 257B - 258B
  • [35] PRELIMINARY RESULTS OF PHASE I/II STUDY OF CLOFARABINE (CLO) IN COMBINATION WITH CYTARABINE AND TOTAL BODY IRRADIATION (TBI) FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS (CAYA) WITH POOR-RISK ACUTE LEUKEMIA
    Ricci, A. M.
    Geyer, M. B.
    Harrison, L. A.
    Duffy, D.
    Bhatia, M.
    Garvin, J. H.
    George, D.
    Satwani, P.
    Cheerva, A. C.
    Talano, J.
    Ozkaynak, M. F.
    Moore, T. B.
    Schwartz, J.
    Baxter-Lowe, L. A.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S186 - S186
  • [36] A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
    Hijiya, N.
    Gaynon, P.
    Barry, E.
    Silverman, L.
    Thomson, B.
    Chu, R.
    Cooper, T.
    Kadota, R.
    Rytting, M.
    Steinherz, P.
    Shen, V.
    Jeha, S.
    Abichandani, R.
    Carroll, W. L.
    LEUKEMIA, 2009, 23 (12) : 2259 - 2264
  • [37] Phase II Study of the Combination of Clofarabine Plus Idarubicin and Cytarabine (CIA) In Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Naqvi, Kiran
    Ravandi, Farhad
    Kantarjian, Hagop
    Borthakur, Gautam
    Ferrajoli, Alessandra
    Thomas, Deborah A.
    Koller, Charles Asa
    Konopleva, Marina
    Byrd, Anna
    Kwari, Monica
    Faderl, Stefan
    BLOOD, 2010, 116 (21) : 464 - 465
  • [38] A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
    N Hijiya
    P Gaynon
    E Barry
    L Silverman
    B Thomson
    R Chu
    T Cooper
    R Kadota
    M Rytting
    P Steinherz
    V Shen
    S Jeha
    R Abichandani
    W L Carroll
    Leukemia, 2009, 23 : 2259 - 2264
  • [39] A Phase I, Dose Escalation Study of Clofarabine in Combination with Fractionated Gemtuzumab Ozogamicin in Relapsed and Refractory Acute Myeloid Leukemia (AML).
    Foster, Matthew C.
    Amin, Chirag
    Voorhees, Peter M.
    Van Deventer, Hendrik W.
    Richards, Kristy L.
    Ivanova, Anastasia
    Whitman, Jennifer
    Shea, Thomas C.
    BLOOD, 2009, 114 (22) : 808 - 809
  • [40] Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia
    Si Lim, Stephanie J.
    Grupp, Stephen A.
    DiNofia, Amanda M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)